Hawai'i State News

Department of Health report identifies opportunities to eliminate Hepatitis C among vulnerable communities

Listen to this Article
1 minute
Loading Audio... Article will play after ad...
Playing in :00

Photo Courtesy: Pexels

In a new report, the Hawai‘i Department of Health confirmed that syringe exchange programs provide important opportunities to eliminate infectious diseases like hepatitis C.

Syringe exchanges not only prevent infections from spreading throughout the community, but also serve as essential health hubs for people who use drugs.

This landmark report used qualitative research methods to seek guidance from people who use drugs on ways to increase the use of curative hepatitis C treatment.


In Hawaiʻi, people diagnosed with hepatitis C may die 20 years earlier than other state residents, according to previous research.

The disease burden is especially high among people who use drugs, with more than half of syringe exchange clients infected with hepatitis C at some point in their lifetime. Although hepatitis C is curable with well-tolerated, all-oral medication, many people in Hawaiʻi report not seeking treatment.

To better understand hepatitis C treatment barriers, DOH conducted interviews with syringe exchange clients in early 2023. The resulting report—“I Wanna Live a Full Life: Perceptions of Hepatitis C Treatment Access among People Who Use Drugs in Honolulu, Hawaiʻi”—is the first Department of Health-led research project that centers on the voices of people who use drugs to guide public health programs.


Based on the interviews, the most important findings from the report include:

  • People who use drugs are concerned with health and disease prevention, although their knowledge about hepatitis C varied.
  • Co-location of hepatitis C treatment and other services at syringe exchanges is an important opportunity to improve health outcomes.
  • People who use drugs respond to visual, directive messaging, especially print materials distributed by syringe exchanges.
  • Perceived stigma around substance use and hepatitis C are ongoing barriers to healthcare.

“The findings of this report reiterate the importance of seeking community voices to ensure effective public health decision-making,” said Diana Felton, chief of the Department of Health Communicable Disease and Public Health Nursing Division. “The voices of local people who use drugs are essential for identifying meaningful opportunities to eliminate hepatitis C in Hawaiʻi.”

Sponsored Content

Subscribe to our Newsletter

Stay in-the-know with daily or weekly
headlines delivered straight to your inbox.


This comments section is a public community forum for the purpose of free expression. Although Big Island Now encourages respectful communication only, some content may be considered offensive. Please view at your own discretion. View Comments